Repro Med Systems Inc (REPR)

[mrholty]

I was not looking for it this morning. I thought it was coming out afterhours since the call is tomorrow. I like usually seeing the 10Q but the press release provides enough to work.

Revenue flat over prior quarter but better margins by 2%.
SG&A are inline but up over the prior quarter. Supposedly driven by increased legal fees and R&D spend.

Nothing too surprising which I guess is good. At a company this size I'd like to see growth both Q over Q and over PY. However we did this same thing where Q3 of 2017 was flat to Q2 2017 and then Q4 was up 7%. I know how hard it is to drive sequential improvement on the top line and I like the comment that they are seeing operating efficiencies. Overall when you take a longer term picture the story is compelling as sales, gross margins and NI both $ and % are up.

I'd like to see a shakeout in the share price to add but I can live with my investment.